randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 - Annals Neurology Efficacy of mecasin for treatment

Efficacy of mecasin for treatment of amyotrophic lateral sclerosis: A phase IIa multicenter randomized double blinded placebo controlled trial ScienceDirect In the randomized, double blind, placebo controlled, global Phase III trial recently presented in the ASCO 2024 annual meeting, consolidation treatment with #durvalumab significantly improved clinical outcomes for patients with limited stage small cell Retrospective observational study on the use of acetyl l carnitine in ALS Journal of Neurology Springer Nature Link Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry

SKU: 48066282260 · From vanierexcavation.com